These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16449118)
1. Cervical intraepithelial neoplasia and cervicovaginal shedding of human immunodeficiency virus. Spinillo A; Zara F; Gardella B; Preti E; Gaia G; Maserati R Obstet Gynecol; 2006 Feb; 107(2 Pt 1):314-20. PubMed ID: 16449118 [TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women. Spinillo A; Debiaggi M; Zara F; De Santolo A; Polatti F; Filice G Obstet Gynecol; 2001 Jun; 97(6):999-1004. PubMed ID: 11384710 [TBL] [Abstract][Full Text] [Related]
3. Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions. Spinillo A; Debiaggi M; Zara F; Maserati R; Polatti F; De Santolo A BJOG; 2001 Jun; 108(6):634-41. PubMed ID: 11426900 [TBL] [Abstract][Full Text] [Related]
4. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. Fontaine J; Hankins C; Mayrand MH; Lefevre J; Money D; Gagnon S; Rachlis A; Pourreaux K; Ferenczy A; Coutlée F; AIDS; 2005 May; 19(8):785-94. PubMed ID: 15867492 [TBL] [Abstract][Full Text] [Related]
5. HIV shedding in cervico-vaginal secretions in pregnant women. Gardella B; Roccio M; Maccabruni A; Mariani B; Panzeri L; Zara F; Spinillo A Curr HIV Res; 2011 Jul; 9(5):313-20. PubMed ID: 21916839 [TBL] [Abstract][Full Text] [Related]
6. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. Debiaggi M; Zara F; Spinillo A; De Santolo A; Maserati R; Bruno R; Sacchi P; Achilli G; Pistorio A; Romero E; Filice G Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):91-6. PubMed ID: 11305478 [TBL] [Abstract][Full Text] [Related]
7. Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy? Huchko MJ; Woo V; Liegler T; Leddy A; Smith-McCune K; Sawaya GF; Bukusi EA; Cohen CR J Low Genit Tract Dis; 2013 Jul; 17(3):354-60. PubMed ID: 23486070 [TBL] [Abstract][Full Text] [Related]
8. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes. LeGoff J; Weiss HA; Gresenguet G; Nzambi K; Frost E; Hayes RJ; Mabey DC; Malkin JE; Mayaud P; Belec L AIDS; 2007 Jul; 21(12):1569-78. PubMed ID: 17630552 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis-related proteins and cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Spinillo A; Zara F; Zappatore R; Cesari S; Bergante C; Morbini P Gynecol Oncol; 2004 Dec; 95(3):500-5. PubMed ID: 15581953 [TBL] [Abstract][Full Text] [Related]
10. Papillomavirus in cervicovaginal smears of women infected with human immunodeficiency virus. Eduardo Calore E; José Cavaliere M; Kasumi Shirata N; Araújo MF Sao Paulo Med J; 1995; 113(6):1009-11. PubMed ID: 8731285 [TBL] [Abstract][Full Text] [Related]
11. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. Xi LF; Koutsky LA; Galloway DA; Kuypers J; Hughes JP; Wheeler CM; Holmes KK; Kiviat NB J Natl Cancer Inst; 1997 Jun; 89(11):796-802. PubMed ID: 9182978 [TBL] [Abstract][Full Text] [Related]
12. The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions. Spinillo A; Zara F; Gardella B; Preti E; Mainini R; Maserati R Am J Obstet Gynecol; 2005 Mar; 192(3):774-9. PubMed ID: 15746671 [TBL] [Abstract][Full Text] [Related]
13. Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management. Spitzer M Obstet Gynecol Surv; 1999 Feb; 54(2):131-7. PubMed ID: 9950005 [TBL] [Abstract][Full Text] [Related]
14. Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. Massad LS; Fazzari MJ; Anastos K; Klein RS; Minkoff H; Jamieson DJ; Duerr A; Celentano D; Gange S; Cu-Uvin S; Young M; Watts DH; Levine AM; Schuman P; Harris TG; Strickler HD J Low Genit Tract Dis; 2007 Apr; 11(2):90-7. PubMed ID: 17415113 [TBL] [Abstract][Full Text] [Related]
15. Detection of cytokines in cervicovaginal lavage in HIV-infected women and its association with high-risk human papillomavirus. Schindler S; Netto E; Deminco F; Figueiredo CA; de Andrade CM; Alves AR; Brites C Front Immunol; 2024; 15():1416204. PubMed ID: 39007140 [TBL] [Abstract][Full Text] [Related]
16. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871 [TBL] [Abstract][Full Text] [Related]
17. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). Heard I; Tassie JM; Schmitz V; Mandelbrot L; Kazatchkine MD; Orth G Obstet Gynecol; 2000 Sep; 96(3):403-9. PubMed ID: 10960634 [TBL] [Abstract][Full Text] [Related]
18. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study. Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K Eur J Gynaecol Oncol; 2004; 25(6):689-98. PubMed ID: 15597844 [TBL] [Abstract][Full Text] [Related]
19. Are benign cellular changes on a Papanicolaou smear really benign? A prospective cohort study. Margolis KL; Carson LF; Setness PA; Stanley MW; Henry-Stanley MJ; Beneke J; Linzie B; McGlennen RC Arch Fam Med; 1999; 8(5):433-9. PubMed ID: 10500518 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]